Published on 2 Nov 2023 on Simply Wall St. via Yahoo Finance
Several Insiders Invested In Cyclo Therapeutics Flagging Positive News
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Cyclo Therapeutics, Inc. (NASDAQ:CYTH), it sends a favourable message to the company's shareholders.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
See our latest analysis for Cyclo Therapeutics